Study reveals why some women with deadly ovarian cancer respond better to treatment than others

FHS
June 21, 2023
7:16 pm

New research is increasing our understanding about why some women with the most lethal form of ovarian cancer respond much better to treatment than others.

Ultimovacs bags orphan drug tag for mesothelioma vaccine –

Ultimovac’s cancer vaccine UV1 triggers an immune response against malignant plural mesothelioma. Image Credit: Shutterstock/Sergey Nivens Ultimovacs has received an orphan drug designation from the

October 9, 2023

Element raises $277M to challenge Illumina in sequencing market

Dive Brief: Element Biosciences said Wednesday it raised $277 million in a Series D financing round, giving the company additional capital to challenge Illumina in

July 12, 2024

FTC sues private equity firm Welsh Carson, U.S. Anesthesia Partners for allegedly creating a monopoly

The Federal Trade Commission has sued U.S. Anesthesia Partners and its private equity owner, Welsh, Carson, Anderson & Stowe, alleging in federal court the two

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.